A clinical GMP facility is available at the hospital site. The unit aims to have broad accreditations in several fields, in order to accommodate the translation of internal research to clinical trials, and to provide support for commercial clinical trials in the field of gene, cell and tissue engineering.
This unit is currently accredited for mRNA production, dendritic cell manipulation and filling and packaging of cell products.
The unit will expand its capabilities with accreditations for on-site viral vector production and clinical grade CAR T production. Further expansion of the accreditations in the field of gene, cell and tissue therapies is planned over the coming years.
Nico Callewaert is group leader and director of the VIB-UGent Center for Medical Biotechnology and full professor in biochemistry and biotechnology at Ghent University. His research interests focus on the invention of technologies for medicine, proteins and sugars.
Prof. Jolanda van Hengel is heading the medical cell biology group. Her group focuses on the in vitro engineering of functional myocardium that mimics human heart tissue for analysis of myocardial function. Also her group tries to obtain a suitable stem cell type for in vitro meat production.